Physician profile
Danielle Mitsch
NPI 1063081206
$664.23
in general payments reported to CMS, 2019-2025
17 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $62.18 · 2023: $228 · 2024: $217 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $602.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $116.04 | 2022-2024 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $109.41 | 2023-2025 | Caplyta |
| Tris Pharma INC | $60.03 | 2022-2023 | Dyanavel Xr |
| Lundbeck LLC | $51.37 | 2023-2025 | Rexulti |
| Neos Therapeutics, LP | $48.40 | 2023-2024 | Adzenys Xr-Odt |
| Almatica Pharma LLC | $40.08 | 2023 | Loreev Xr |
| Collegium Pharmaceutical, INC. | $36.67 | 2025 | Jornay Pm |
| Tempus Ai, INC | $36.45 | 2024 | Tempus Pixel |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $25.00 | 2025 | |
| Tms Neurohealth Centers INC. | $22.85 | 2025 | Tms Neurohealth Centers INC. |
| Vertical Pharmaceuticals, LLC | $18.93 | 2024 | Relexxii |
| Abbvie INC. | $18.82 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $18.02 | 2023 | Rexulti, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $17.28 | 2024 | Fanapt, Hetlioz |
| Idorsia Pharmaceuticals US INC | $16.70 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $14.98 | 2024 | Aristada, Lybalvi |
| Axsome Therapeutics, INC. | $13.20 | 2024 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mitsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.